Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a…

Overview of attention for article published in Journal of Patient-Reported Outcomes, April 2018

Altmetric Badge

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Article in Digestive and Liver Disease (May 2024)

Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

Article in Journal of Crohn's and Colitis (April 2024)

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study

Article in Inflammatory Bowel Diseases (February 2022)